Pune, India -- (SBWIRE) -- 05/08/2020 -- Infinium Global Research has recently published a global report on "Autoimmune Disease Drug Market (Indication - Diabetes Mellitus Type 1, Rheumatic Diseases, Multiple Sclerosis, Rare Diseases, and Other Indication; Drug Class - NSAIDs, Anti-inflammatory, Interferons, Antihyperglycemic, Immunosuppressants, and Other Drug Class; Distribution Channel - Hospital Pharmacies, Online Stores, and Retail Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025."

To Know More Request Sample of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/15267

Rising Number of Autoimmune Disease Populations is the Major Key Driving Factor

The autoimmune disease drug market is expected to grow at a significant rate during the forecast period. As per the study of the National Institute of Health, more than 80 diseases occur as a result of the immune system attacking the body's organs, tissues, and cells. Considering the prevalence of more than 23.5 million Americans are affected by autoimmune diseases, out of which 75% are women. Thus a rising number of autoimmune disease populations is the major key factor driving the market.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Autoimmune Disease Drug Market is Included in the Report for Free."

Technological Advancement Will Fuel the Autoimmune Disease Drug Market in the Future

Moreover, growing assistance of government and private sectors, increasing reimbursement policies are also contributing to the growth of the market. However, difficulties in diagnosis due to minimal learning about autoimmune diseases and its symptoms as well as long-term side effects of the drugs may restrain the market. However, an increase in biopharmaceutical research companies to develop innovative drugs and innovative approaches for treatment as well as a rise in funding for technological advancement will fuel the autoimmune disease drug market in the future.

North America Dominates the Autoimmune Disease Drug Market

Geographically, the market is categorized into North America, Europe, Asia Pacific, and RoW. North America dominates the market owing to the growing prevalence of the autoimmune disease, additionally, rising research activities to accelerate the development of new treatment options in this region.

Europe market holds the second position in the market owing to its rising awareness regarding autoimmune diseases and crucial steps taken by the government and private sectors to improve diagnosis, prevention, and management of the disease. The market in the Asia Pacific region tends to increase in the forecast period due to an increase in healthcare expenditures.

Get this Section as a Free Customization in the Report Along With 30% Discount on the Study. https://www.infiniumglobalresearch.com/reports/customization/15267

"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Autoimmune Disease Drug Amidst COVID-19"

Autoimmune Disease Drug Market Coverage

Chapter - 1     Preface

=> Report Description

=> Research Methods

=> Research Approaches

Chapter - 2     Executive Summary

=> Autoimmune Disease Drug Market Highlights

=> Autoimmune Disease Drug Market Projection

=> Autoimmune Disease Drug Market Regional Highlights

Chapter - 3     Global Autoimmune Disease Drug Market Overview

=> Introduction

=> Market Dynamics

=> Porter's Five Forces Analysis

=> IGR-Growth Matrix Analysis

=> Value Chain Analysis of Autoimmune Disease Drug Market

Chapter - 4     Autoimmune Disease Drug Market Macro Indicator Analysis

Chapter - 5     Global Autoimmune Disease Drug Market by Indication

=> Diabetes Mellitus Type 1

=> Rheumatic Diseases

=> Multiple Sclerosis

=> Rare Diseases

=> Other Indication

Chapter - 6     Global Autoimmune Disease Drug Market by Drug Class

=> NSAIDs

=> Anti-inflammatory

=> Interferons

=> Antihyperglycemic

=> Immunosuppressants

=> Other Drug Class

Chapter - 7     Global Autoimmune Disease Drug Market by Distribution Channel

=> Hospital Pharmacies

=> Online Stores

=> Retail Pharmacies

Chapter - 8     Global Autoimmune Disease Drug Market by Region 2019-2025

=> North America

=> Europe

=> Asia-Pacific

=> RoW

Chapter - 9     Company Profiles and Competitive Landscape

=> F. Hoffmann-La Roche AG

=> Abbott Laboratories

=> Bristol-Myers Squibb Company

=> Amgen Inc.

=> Johnson & Johnson

=> AstraZeneca plc.

=> Pfizer Inc.

=> Novartis AG

=> Other Companies

Chapter - 10  Appendix

=> Primary Research Findings and Questionnaire

Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-autoimmune-disease-drug-market

About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.